Gatifloxacin pentahydrate
US6413969B1 · kind B1 · utility
4Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 2001 |
| Grant date | Jul 2, 2002 |
| Priority date | — |
| Expiry date | Aug 17, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are provided in accordance with the present invention crystalline gatifloxacin pentahydrate represented by the formula in a highly homogeneous form with respect to other crystalline forms thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.